Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells

Cell Death & Disease
Junhui YuJianbao Zheng

Abstract

Pyroptosis, a form of programmed cell death (PCD), has garnered increasing attention as it relates to innate immunity and diseases. However, the involvement of pyroptosis in the mechanism by which lobaplatin acts against colorectal cancer (CRC) is unclear. Our study revealed that treatment with lobaplatin reduced the viability of HT-29 and HCT116 cells in a dose-dependent manner. Morphologically, HT-29 and HCT116 cells treated with lobaplatin exhibited microscopic features of cell swelling and large bubbles emerging from the plasma membrane, and transmission electron microscopy (TEM) revealed multiple pores in the membrane. GSDME, rather than GSDMD, was cleaved in lobaplatin-induced pyroptosis in HT-29 and HCT116 cells due to caspase-3 activation. Knocking out GSDME switched lobaplatin-induced cell death from pyroptosis to apoptosis but did not affect lobaplatin-mediated inhibition of growth and tumour formation of HT-29 and HCT116 cells in vivo and in vitro. Further investigation indicates that lobaplatin induced reactive oxygen species (ROS) elevation and JNK phosphorylation. NAC, a ROS scavenger, completely reversed the pyroptosis of lobaplatin-treated HT-29 and HCT116 and JNK phosphorylation. Activated JNK recruited Bax to ...Continue Reading

References

Oct 15, 1998·Nature Genetics·L Van LaerG Van Camp
Oct 26, 2005·Cell Death and Differentiation·Y Tsujimoto, S Shimizu
Mar 17, 2006·Free Radical Biology & Medicine·Han-Ming Shen, Zheng-gang Liu
Aug 10, 2006·Journal of Human Genetics·Yoshiko MasudaHirofumi Arakawa
Nov 7, 2006·Cancer Science·Kimishige AkinoTakashi Tokino
Feb 10, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John P Fruehauf, Frank L Meyskens
Mar 19, 2008·Biochemical and Biophysical Research Communications·Myoung Sook KimDavid Sidransky
Dec 17, 2009·Cell Death and Differentiation·T Vanden BergheP Vandenabeele
Oct 18, 2011·Nature·Nobuhiko KayagakiVishva M Dixit
Apr 4, 2012·The Lancet Oncology·Nicholas C Turner, Jorge S Reis-Filho
Jul 4, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Martina KovarovaBeverly H Koller
Dec 12, 2012·Cell·Justin KaleDavid W Andrews
May 25, 2013·Nature Reviews. Immunology·Eicke LatzAndrea Stutz
Jul 28, 2013·Science·Nobuhiko KayagakiVishva M Dixit
Nov 26, 2013·Annals of Surgical Oncology·Bridget N Fahy
Dec 21, 2013·Nature·Gilad DoitshWarner C Greene
May 27, 2014·Cell·Mohamed Lamkanfi, Vishva M Dixit
Jun 7, 2014·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·L CampisiJ Magarian Blander
Dec 18, 2014·World Journal of Gastroenterology : WJG·Chu-Yang YinXiu-Ying Xiao
Feb 11, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Fangfang YangYuquan Wei
Apr 17, 2015·Immunological Reviews·Ine Jorgensen, Edward A Miao
Aug 25, 2015·The Journal of General Virology·Lin DengHak Hotta
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Mar 8, 2016·Brain Research·Rahul Patel, Federico Sesti
Oct 25, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yali LiChengjian Zhao
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Apr 14, 2017·Oncotarget·Lieselot CroesGuy Van Camp

❮ Previous
Next ❯

Citations

Nov 5, 2019·American Journal of Physiology. Renal Physiology·Yuanyuan LiZhanjun Jia
Jan 4, 2020·Parasitology Research·Yuanyuan XiaMiao Liu
Jun 13, 2019·The Journal of Experimental Medicine·David E Place, Thirumala-Devi Kanneganti
Apr 3, 2020·Journal of Cell Communication and Signaling·Danbin WuMaojuan Guo
Sep 11, 2019·Cell Death & Disease·Xiaojing XiaJianhe Hu
Feb 26, 2020·International Journal of Molecular Sciences·Zhaodi Zheng, Guorong Li
Aug 12, 2020·Journal of Hematology & Oncology·Rong TangSi Shi
Oct 6, 2020·Journal of Immunology Research·Liliana R BalahuraMarieta Costache
Oct 17, 2019·Frontiers in Oncology·Yan-Yang WangRen Zhao
Oct 10, 2020·Clinical & Translational Immunology·Lipeng TangBoudewijn Mt Burgering
Jan 11, 2021·Trends in Cancer·J IbrahimK Op de Beeck
Apr 23, 2019·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Nardhy Gomez-LopezChaur-Dong Hsu
May 13, 2020·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Bin ZhangHuan-Rong Zhang
Feb 23, 2021·Frontiers in Oncology·Rilei JiangJiang Wu
Feb 27, 2021·Frontiers in Cell and Developmental Biology·Man WangYuan Zhang
Feb 26, 2021·Biochemical and Biophysical Research Communications·Jing GuoJunhui Yu
Mar 16, 2021·Frontiers in Oncology·Lei WangPengfei Ge
Mar 28, 2021·Trends in Cell Biology·Elke De SchutterPeter Vandenabeele
Mar 23, 2021·Biochimie·Xiaoli JuQiang Wang
Mar 30, 2021·Signal Transduction and Targeted Therapy·Pian YuXiang Chen
Nov 14, 2020·International Journal of Cancer. Journal International Du Cancer·Elke De SchutterGuy Van Camp

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
transfections
PCR
Assay
ELISA
transmission electron microscopy
xenograft
transfection
transfecton

Software Mentioned

SPSS

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.